A debate. Estenosis aórtica grave asintomática, ¿es el momento de actuar? Perspectiva del intervencionista

  1. José A. Baz Alonso 1
  1. 1 Unidad de Cardiología Intervencionista, Hospital Álvaro Cunqueiro, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra, España
Revista:
REC: Interventional Cardiology

ISSN: 2604-7276 2604-7306

Año de publicación: 2024

Volumen: 6

Número: 1

Páginas: 43-45

Tipo: Artículo

DOI: 10.24875/RECIC.M23000419 DIALNET GOOGLE SCHOLAR lock_openDialnet editor

Otras publicaciones en: REC: Interventional Cardiology

Referencias bibliográficas

  • 1. Ross J, Braunwald E. Aortic stenosis. Circulation. 1968;38 suppl V:61-67.
  • 2. Kang DH, Park SCJ, Rim JH, et al. Early surgery versus conventional treatment in asymptomatic very severe aortic stenosis. Circulation. 2010;121:1502-1509.
  • 3. Taniguchi T, Morimoto T, Shiomi H, et al. Initial surgical versus conservative strategies in patients with asymptomatic severe aortic stenosis. J Am Coll Cardiol. 2015;66:2827-2838.
  • 4. Kang D-H, Park S-J, Lee S-A, et al. Early surgery or conservative care for asymptomatic aortic stenosis. N Engl J Med. 2020;382:111-119.
  • 5. Banovic M, Putnik S, Penicka M, et al. Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis:the AVATAR trial. Circulation. 2022;145:648-658.
  • 6. Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43:561-632.
  • 7. Popma JJ, Deeb GM, Yakubov SJ, et al. Evolut Low Risk Trial Investigators. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380:1706-1715.
  • 8. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-||aaexpandable valve in low risk patients. N Engl J Med. 2019;380:1695-1705.